Your browser doesn't support javascript.
loading
Lipoprotein(a) in Youth and Prediction of Major Cardiovascular Outcomes in Adulthood.
Raitakari, Olli; Kartiosuo, Noora; Pahkala, Katja; Hutri-Kähönen, Nina; Bazzano, Lydia A; Chen, Wei; Urbina, Elaine M; Jacobs, David R; Sinaiko, Alan; Steinberger, Julia; Burns, Trudy; Daniels, Stephen R; Venn, Alison; Woo, Jessica G; Dwyer, Terry; Juonala, Markus; Viikari, Jorma.
Afiliação
  • Raitakari O; Centre for Population Health Research, University of Turku and Turku University Hospital, Finland (O.R., N.K., K.P.).
  • Kartiosuo N; Research Centre of Applied and Preventive Cardiovascular Medicine (O.R., N.K., K.P.), University of Turku, Finland.
  • Pahkala K; Department of Clinical Physiology and Nuclear Medicine (O.R.), Turku University Hospital, Finland.
  • Hutri-Kähönen N; Centre for Population Health Research, University of Turku and Turku University Hospital, Finland (O.R., N.K., K.P.).
  • Bazzano LA; Research Centre of Applied and Preventive Cardiovascular Medicine (O.R., N.K., K.P.), University of Turku, Finland.
  • Chen W; Centre for Population Health Research, University of Turku and Turku University Hospital, Finland (O.R., N.K., K.P.).
  • Urbina EM; Research Centre of Applied and Preventive Cardiovascular Medicine (O.R., N.K., K.P.), University of Turku, Finland.
  • Jacobs DR; Paavo Nurmi Centre and Unit for Health and Physical Activity (K.P.), University of Turku, Finland.
  • Sinaiko A; Tampere Centre for Skills Training and Simulation, Tampere University, Finland (N.H.-K.).
  • Steinberger J; Department of Epidemiology, School of Public Health and Tropical Medicine, Tulane University, New Orleans, LA (L.A.B., W.C.).
  • Burns T; Department of Epidemiology, School of Public Health and Tropical Medicine, Tulane University, New Orleans, LA (L.A.B., W.C.).
  • Daniels SR; Department of Pediatrics, University of Cincinnati College of Medicine, OH (E.M.U., J.G.W.).
  • Venn A; The Heart Institute (E.M.U.), Cincinnati Children's Hospital Medical Center, OH.
  • Woo JG; Division of Epidemiology and Community Health, School of Public Health, University of Minnesota, Minneapolis (D.R.J.).
  • Dwyer T; Department of Pediatrics, University of Minnesota Medical School, Minneapolis (A.S., J.S.).
  • Juonala M; Department of Pediatrics, University of Minnesota Medical School, Minneapolis (A.S., J.S.).
  • Viikari J; Department of Medicine (M.J., J.V.), University of Turku, Finland.
Circulation ; 147(1): 23-31, 2023 01 03.
Article em En | MEDLINE | ID: mdl-36440577
BACKGROUND: Elevated lipoprotein(a) [Lp(a)] is a common risk factor for cardiovascular disease outcomes with unknown mechanisms. We examined its potential role in identifying youths who are at increased risk of developing adult atherosclerotic cardiovascular disease (ASCVD). METHODS: Lp(a) levels measured in youth 9 to 24 years of age were linked to adult ASCVD and carotid intima-media thickness in the YFS (Cardiovascular Risk in Young Finns Study), in which 95 of the original 3596 participants (2.7%) recruited as children have been diagnosed with ASCVD at a median of 47 years of age. Results observed in YFS were replicated with the use of data for White participants from the BHS (Bogalusa Heart Study). In BHS, 587 White individuals had data on youth Lp(a) (measured at 8-17 years of age) and information on adult events, including 15 cases and 572 noncases. Analyses were performed with the use of Cox proportional hazard regression. RESULTS: In YFS, those who had been exposed to high Lp(a) level in youth [defined as Lp(a) ≥30 mg/dL] had ≈2 times greater risk of developing adult ASCVD compared with nonexposed individuals (hazard ratio, 2.0 [95% CI, 1.4-2.6]). Youth risk factors, including Lp(a), low-density lipoprotein cholesterol, body mass index, and smoking, were all independently associated with higher risk. In BHS, in an age- and sex-adjusted model, White individuals who had been exposed to high Lp(a) had 2.5 times greater risk (95% CI, 0.9-6.8) of developing adult ASCVD compared with nonexposed individuals. When also adjusted for low-density lipoprotein cholesterol and body mass index, the risk associated with high Lp(a) remained unchanged (hazard ratio, 2.4 [95% CI, 0.8-7.3]). In a multivariable model for pooled data, individuals exposed to high Lp(a) had 2.0 times greater risk (95% CI, 1.0-3.7) of developing adult ASCVD compared with nonexposed individuals. No association was detected between youth Lp(a) and adult carotid artery thickness in either cohort or pooled data. CONCLUSIONS: Elevated Lp(a) level identified in youth is a risk factor for adult atherosclerotic cardiovascular outcomes but not for increased carotid intima-media thickness.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doenças Cardiovasculares / Aterosclerose Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Child / Humans Idioma: En Revista: Circulation Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doenças Cardiovasculares / Aterosclerose Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Child / Humans Idioma: En Revista: Circulation Ano de publicação: 2023 Tipo de documento: Article